CRP and cancer: Hence, the idea that CRP itself, in its monomeric, modified form, is present within tumors and might act as a participant in the pathological process has added a new and intriguing layer to this hypothesis and may profoundly change the view on how the local inflammatory response in cancer potentially can be targeted.